Bio-Rad Laboratories, Inc. Class A (BIO) earnings
BIO earnings moved a median of -0.12% by the close. Quarterly and annual BIO reports and results, each read against the price at its own news timestamp. Back to the BIO overview →
28 measured BIO earnings events.
Where these BIO earnings landedvs 28 measured BIO earnings reactions
| Middle 50% of BIO earnings reactions | -1.93% to +2.01% |
|---|---|
| Median reaction (to close) | -0.12% |
| Measured reactions | 28 |
Point-in-time · zero look-ahead
Half of the 28 BIO earnings events with a measured close landed between -1.93% and +2.01%; 46% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bio-Rad to Report Third-Quarter 2026 Financial Results on Wednesday, November 4, 2026 | Press release | +0.77% | -0.29% | |
| Bio-Rad Reports Second-Quarter 2026 Financial Results | Press release | +0.21% | +2.31% | |
| Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026 | Press release | +2.00% | +2.56% | |
| Bio-Rad Reports First-Quarter 2026 Financial Results | Press release | -1.68% | -1.88% | |
| Form 10-Q BIO-RAD LABORATORIES, For: Mar 31 | SEC filing · Form 10-Q | -1.68% | -1.88% | |
| Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026 | Press release | -0.04% | +1.39% | |
| Form 10-K BIO-RAD LABORATORIES, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -3.19% | |
| Bio-Rad Reports Third-Quarter 2025 Financial Results | Press release | +3.46% | -3.60% | |
| Form 10-Q BIO-RAD LABORATORIES, For: Sep 30 | SEC filing · Form 10-Q | +3.46% | -3.60% | |
| Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025 | Press release | +0.67% | +0.40% | |
| Bio-Rad Reports Second-Quarter 2025 Financial Results | Press release | -1.07% | +2.57% | |
| Form 10-Q BIO-RAD LABORATORIES, For: Jun 30 | SEC filing · Form 10-Q | -1.07% | +2.57% | |
| Bio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025 | Press release | -0.97% | -2.16% | |
| Bio-Rad Reports First-Quarter 2025 Financial Results | Press release | -3.13% | -5.46% | |
| Form 10-Q BIO-RAD LABORATORIES, For: Mar 31 | SEC filing · Form 10-Q | -3.13% | -5.46% | |
| Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 | Press release | -0.61% | -0.62% | |
| Form 10-K BIO-RAD LABORATORIES, For: Dec 31 | SEC filing · Form 10-K | +0.03% | +2.80% | |
| Form 10-Q BIO-RAD LABORATORIES, For: Sep 30 | SEC filing · Form 10-Q | +0.09% | +1.52% | |
| Bio-Rad Reports Third-Quarter 2024 Financial Results | Press release | -1.71% | +2.34% | |
| Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024 | Press release | +0.26% | -0.06% | |
| Form 10-Q BIO-RAD LABORATORIES, For: Jun 30 | SEC filing · Form 10-Q | -2.81% | +0.89% | |
| Bio-Rad Reports Second-Quarter 2024 Financial Results | Press release | -0.15% | -0.18% | |
| Form 10-Q BIO-RAD LABORATORIES, For: Mar 31 | SEC filing · Form 10-Q | +0.62% | +3.15% | |
| Bio-Rad Reports First-Quarter 2024 Financial Results | Press release | -0.51% | -1.56% | |
| Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 | Press release | -0.96% | +1.26% | |
| Form 10-K BIO-RAD LABORATORIES, For: Dec 31 | SEC filing · Form 10-K | +0.85% | +1.92% | |
| Form 10-Q BIO-RAD LABORATORIES, For: Sep 30 | SEC filing · Form 10-Q | -0.10% | -2.08% | |
| Bio-Rad Reports Third-Quarter 2023 Financial Results | Press release | -0.70% | -1.36% |
Keep exploring
More BIO: analyst actions → · SEC filings → · BIO overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Omeros Corporation (OMER) | 232 | +0.49% | 57% |
| SANUWAVE Health, Inc. (SNWV) | 232 | 0.00% | 49% |
| Cronos Group Inc. - Common Share (CRON) | 230 | +0.27% | 62% |
| Forward Pharma A/S - American Depositary Shares (FWP) | 230 | 0.00% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.